1Barter, PJ, Caulfield, M, Eriksson, M, et al. (2007) Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 357, 2109–2122.
2Wilson, PW, Abbott, RD & Castelli, WP (1988) High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis 8, 737–741.
3Glomset, JA (1968) The plasma lecithins:cholesterol acyltransferase reaction. J Lipid Res 9, 155–167.
4Wang, N, Lan, D, Chen, W, et al. (2004) ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci U S A 101, 9774–9779.
5Bortnick, AE, Rothblat, GH, Stoudt, G, et al. (2000) The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines. J Biol Chem 275, 28634–28640.
6Ruano, J, Lopez-Miranda, J, Fuentes, F, et al. (2005) Phenolic content of virgin olive oil improves ischemic reactive hyperemia in hypercholesterolemic patients. J Am Coll Cardiol 46, 1864–1868.
7Tall, AR, Costet, P & Wang, N (2002) Regulation and mechanisms of macrophage cholesterol efflux. J Clin Invest 110, 899–904.
8Yancey, PG, Bortnick, AE, Kellner-Weibel, G, et al. (2003) Importance of different pathways of cellular cholesterol efflux. Arterioscler Thromb Vasc Biol 23, 712–719.
9Smith, JD (2006) Insight into ABCG1-mediated cholesterol efflux. Arterioscler Thromb Vasc Biol 26, 1198–1200.
10Favari, E, Lee, M, Calabresi, L, et al. (2004) Depletion of pre-beta-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1- but not scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein. J Biol Chem 279, 9930–9936.
11Baldan, A, Bojanic, DD & Edwards, PA (2009) The ABCs of sterol transport. J Lipid Res 50, S80–S85.
12Yancey, PG, de la Llera-Moya, M, Swarnakar, S, et al. (2000) High density lipoprotein phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI. J Biol Chem 275, 36596–36604.
13Brunner, E & Iso, H (2008) Fish oil and secondary prevention of cardiovascular disease. BMJ 337, a2541.
14Ordovas, JM, Kaput, J & Corella, D (2007) Nutrition in the genomics era: cardiovascular disease risk and the Mediterranean diet. Mol Nutr Food Res 51, 1293–1299.
15Hu, FB, Stampfer, MJ, Manson, JE, et al. (1997) Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 337, 1491–1499.
16Visioli, F, Poli, A & Gall, C (2002) Antioxidant and other biological activities of phenols from olives and olive oil. Med Res Rev 22, 65–75.
17Lopez-Miranda, J, Perez-Jimenez, F, Ros, E, et al. (2010) Olive oil and health: summary of the II international conference on olive oil and health consensus report, Jaen and Cordoba (Spain) 2008. Nutr Metab Cardiovasc Dis 20, 284–294.
18Castaner, O, Fito, M, Lopez-Sabater, MC, et al. (2011) The effect of olive oil polyphenols on antibodies against oxidized LDL. A randomized clinical trial. Clin Nutr 30, 490–493.
19Covas, MI, de la Torre, K, Farre-Albaladejo, M, et al. (2006) Postprandial LDL phenolic content and LDL oxidation are modulated by olive oil phenolic compounds in humans. Free Radic Biol Med 40, 608–616.
20Aviram, M & Eias, K (1993) Dietary olive oil reduces low-density lipoprotein uptake by macrophages and decreases the susceptibility of the lipoprotein to undergo lipid peroxidation. Ann Nutr Metab 37, 75–84.
21Nicolaiew, N, Lemort, N, Adorni, L, et al. (1998) Comparison between extra virgin olive oil and oleic acid rich sunflower oil: effects on postprandial lipemia and LDL susceptibility to oxidation. Ann Nutr Metab 42, 251–260.
22Aguilera, CM, Mesa, MD, Ramirez-Tortosa, MC, et al. (2004) Sunflower oil does not protect against LDL oxidation as virgin olive oil does in patients with peripheral vascular disease. Clin Nutr 23, 673–681.
23Rodenas, S, Rodriguez-Gil, S, Merinero, MC, et al. (2005) Dietary exchange of an olive oil and sunflower oil blend for extra virgin olive oil decreases the estimate cardiovascular risk and LDL and apolipoprotein AII concentrations in postmenopausal women. J Am Coll Nutr 24, 361–369.
24Perez-Jimenez, F, Espino, A, Lopez-Segura, F, et al. (1995) Lipoprotein concentrations in normolipidemic males consuming oleic acid-rich diets from two different sources: olive oil and oleic acid-rich sunflower oil. Am J Clin Nutr 62, 769–775.
25Perona, JS, Canizares, J, Montero, E, et al. (2004) Virgin olive oil reduces blood pressure in hypertensive elderly subjects. Clin Nutr 23, 1113–1121.
26Movva, R & Rader, DJ (2008) Laboratory assessment of HDL heterogeneity and function. Clin Chem 54, 788–800.
27Sola, R, Motta, C, Maille, M, et al. (1993) Dietary monounsaturated fatty acids enhance cholesterol efflux from human fibroblasts. Relation to fluidity, phospholipid fatty acid composition, overall composition, and size of HDL3. Arterioscler Thromb 13, 958–966.
28Rosenblat, M, Volkova, N, Coleman, R, et al. (2008) Antiatherogenicity of extra virgin olive oil and its enrichment with green tea polyphenols in the atherosclerotic apolipoprotein-E-deficient mice: enhanced macrophage cholesterol efflux. J Nutr Biochem 19, 514–523.
29Khallouki, F, Younos, C, Soulimani, R, et al. (2003) Consumption of argan oil (Morocco) with its unique profile of fatty acids, tocopherols, squalene, sterols and phenolic compounds should confer valuable cancer chemopreventive effects. Eur J Cancer Prev 12, 67–75.
30Ruiz-Gutierrez, V, Juan, ME, Cert, A, et al. (2000) Determination of hydroxytyrosol in plasma by HPLC. Anal Chem 72, 4458–4461.
31Sattler, W, Mohr, D & Stocker, R (1994) Rapid isolation of lipoproteins and assessment of their peroxidation by high-performance liquid chromatography postcolumn chemiluminescence. Methods Enzymol 233, 469–489.
32Chinetti, G, Griglio, S, Antonucci, M, et al. (1998) Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages. J Biol Chem 273, 25573–25580.
33Kaplan, R, Gan, X, Menke, JG, et al. (2002) Bacterial lipopolysaccharide induces expression of ABCA1 but not ABCG1 via an LXR-independent pathway. J Lipid Res 43, 952–959.
34Apostolou, F, Gazi, IF, Kostoula, A, et al. (2009) Persistence of an atherogenic lipid profile after treatment of acute infection with Brucella. J Lipid Res 50, 2532–2539.
35Berrougui, H, Isabelle, M, Cloutier, M, et al. (2007) Age-related impairment of HDL-mediated cholesterol efflux. J Lipid Res 48, 328–336.
36Beck, R, Bertolino, S, Abbot, SE, et al. (1998) Modulation of arachidonic acid release and membrane fluidity by albumin in vascular smooth muscle and endothelial cells. Circ Res 83, 923–931.
37Shao, B, Tang, C, Heinecke, JW, et al. (2010) Oxidation of apolipoprotein A-I by myeloperoxidase impairs the initial interactions with ABCA1 required for signaling and cholesterol export. J Lipid Res 51, 1849–1858.
38Waddington, EI, Boadu, E & Francis, GA (2005) Cholesterol and phospholipid efflux from cultured cells. Methods 36, 196–206.
39Wang, N, Silver, DL, Costet, P, et al. (2000) Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1. J Biol Chem 275, 33053–33058.
40Keys, A, Menotti, A, Karvonen, MJ, et al. (1986) The diet and 15-year death rate in the seven countries study. Am J Epidemiol 124, 903–915.
41Konstantinidou, V, Covas, MI, Munoz-Aguayo, D, et al. (2010) In vivo nutrigenomic effects of virgin olive oil polyphenols within the frame of the Mediterranean diet: a randomized controlled trial. FASEB J 24, 2546–2557.
42Covas, MI (2007) Olive oil and the cardiovascular system. Pharmacol Res 55, 175–186.
43Estruch, R, Martinez-Gonzalez, MA, Corella, D, et al. (2006) Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med 145, 1–11.
44Bogani, P, Galli, C, Villa, M, et al. (2007) Postprandial anti-inflammatory and antioxidant effects of extra virgin olive oil. Atherosclerosis 190, 181–186.
45de la Torre-Carbot, K, Chavez-Servin, JL, Jauregui, O, et al. (2010) Elevated circulating LDL phenol levels in men who consumed virgin rather than refined olive oil are associated with less oxidation of plasma LDL. J Nutr 140, 501–508.
46Weinbrenner, T, Fito, M, de la Torre, R, et al. (2004) Olive oils high in phenolic compounds modulate oxidative/antioxidative status in men. J Nutr 134, 2314–2321.
47Sola, R, La Ville, AE, Richard, JL, et al. (1997) Oleic acid rich diet protects against the oxidative modification of high density lipoprotein. Free Radic Biol Med 22, 1037–1045.
48Chan, YM, Demonty, I, Pelled, D, et al. (2007) Olive oil containing olive oil fatty acid esters of plant sterols and dietary diacylglycerol reduces low-density lipoprotein cholesterol and decreases the tendency for peroxidation in hypercholesterolaemic subjects. Br J Nutr 98, 563–570.
49Mata, P, Varela, O, Alonso, R, et al. (1997) Monounsaturated and polyunsaturated n-6 fatty acid-enriched diets modify LDL oxidation and decrease human coronary smooth muscle cell DNA synthesis. Arterioscler Thromb Vasc Biol 17, 2088–2095.
50Wang, N, Silver, DL, Thiele, C, et al. (2001) ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein. J Biol Chem 276, 23742–23747.
51Kennedy, MA, Barrera, GC, Nakamura, K, et al. (2005) ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab 1, 121–131.
52Fu, Y (2010) Rate-limiting factors of cholesterol efflux in reverse cholesterol transport: acceptors and donors. Clin Exp Pharmacol Physiol 37, 703–709.
53Wang, X, Collins, HL, Ranalletta, M, et al. (2007) Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. J Clin Invest 117, 2216–2224.
54Sakr, SW, Senault, C, Vacher, D, et al. (1996) Oleic acid-rich fats increase the capacity of postprandial serum to promote cholesterol efflux from Fu5AH cells. Biochim Biophys Acta 1300, 49–55.
55Efrat, M, Rosenblat, M, Mahmood, S, et al. (2009) Di-oleoyl phosphatidylcholine (PC-18:1) stimulates paraoxonase 1 (PON1) enzymatic and biological activities: in vitro and in vivo studies. Atherosclerosis 202, 461–469.
56Bonnefont-Rousselot, D, Motta, C, Khalil, AO, et al. (1995) Physicochemical changes in human high-density lipoproteins (HDL) oxidized by gamma radiolysis-generated oxyradicals. Effect on their cholesterol effluxing capacity. Biochim Biophys Acta 1255, 23–30.
57Sola, R, Fito, M, Estruch, R, et al. (2011) Effect of a traditional Mediterranean diet on apolipoproteins B, A-I, and their ratio: a randomized, controlled trial. Atherosclerosis 218, 174–180.
58Violante, B, Gerbaudo, L, Borretta, G, et al. (2009) Effects of extra virgin olive oil supplementation at two different low doses on lipid profile in mild hypercholesterolemic subjects: a randomised clinical trial. J Endocrinol Invest 32, 794–796.
59Cabello-Moruno, R, Perona, JS, Osada, J, et al. (2007) Modifications in postprandial triglyceride-rich lipoprotein composition and size after the intake of pomace olive oil. J Am Coll Nutr 26, 24–31.
60Uto-Kondo, H, Ayaori, M, Ogura, M, et al. (2010) Coffee consumption enhances high-density lipoprotein-mediated cholesterol efflux in macrophages. Circ Res 106, 779–787.
61Sevov, M, Elfineh, L & Cavelier, LB (2006) Resveratrol regulates the expression of LXR-alpha in human macrophages. Biochem Biophys Res Commun 348, 1047–1054.
62Miles, EA, Wallace, FA & Calder, PC (2001) An olive oil-rich diet reduces scavenger receptor mRNA in murine macrophages. Br J Nutr 85, 185–191.